Login to Your Account

House, Senate tax reform bills take aim at orphan drug credit

By Mark McCarty
Regulatory Editor

Friday, November 10, 2017

While there are important similarities, the U.S. Senate and the House of Representatives have taken different approaches to several matters in their respective tax reform proposals, including the tax credit for clinical studies of orphan drugs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription